Interest-Based Ads

We believe that treatment decisions should be made between you and your health care teams, so please do not stop taking KESIMPTA without talking to your neurologist or medical professional about any questions you may have.

More information about COVID-19 can be found from the Centers for Disease Control and Prevention (CDC) ↗ or the World Health Organization (WHO) ↗.

Additional patient resources are available through these patient advocacy groups:

Multiple Sclerosis Association of America ↗
National Multiple Sclerosis Society ↗

Don’t make any changes to your medication routine that aren’t directed by your doctor. Otherwise, follow the general safety and hygiene guidelines from the experts at the Centers for Disease Control and Prevention ↗, which include handwashing, social distancing, wearing a mask, and cleaning surfaces.

While the US Food and Drug Administration (FDA) has not made any specific warnings for people on immunosuppressant therapies as it relates to COVID-19 at the time this website was published, KESIMPTA is an immunosuppressant and may contribute to a higher risk or severity of infections because of its suppressive effect on the immune system. Every person has different risks and medical conditions.

It’s important to take precautions to reduce your risk of contracting COVID-19 and to seek medical care if you think you’ve been infected. Talk to your doctor or health care team about any concerns you have about your health.

Additional patient resources are available through these patient advocacy groups:

Multiple Sclerosis Association of America ↗
National Multiple Sclerosis Society ↗

It’s completely understandable to have questions about getting a COVID-19 vaccine if you’re about to start taking KESIMPTA. Vaccines like the COVID-19 vaccines are an important part of public health.

As of December 2021, the available COVID-19 vaccines are inactivated, or “non-live,” vaccines. Whenever possible, you should wait at least 2 weeks after getting an inactivated or “non-live” vaccine to begin taking KESIMPTA.

The KESIMPTA Prescribing Information does not advise against administering inactivated vaccines while on treatment; however, KESIMPTA may interfere with the effectiveness of inactivated vaccines. Your doctor may want to consider an assessment of your immune response after taking the vaccine to confirm it was effective.

You should talk to your doctor to better understand the types of vaccines available to you and how they may affect when you can begin your new treatment.

For more information about COVID-19 vaccines, visit the Centers for Disease Control and Prevention (CDC) website at CDC.gov ↗, and search: COVID-19 vaccines.

It’s completely understandable to have questions about getting a COVID-19 vaccine. Vaccines like the COVID-19 vaccines are an important part of public health.

As of December 2021, the available COVID-19 vaccines are inactivated, or “non-live,” vaccines. The KESIMPTA Prescribing Information does not advise against administering inactivated vaccines while on treatment; however, KESIMPTA may interfere with the effectiveness of inactivated vaccines. Your doctor may want to consider an assessment of your immune response after taking the vaccine to confirm it was effective.

You should talk to your doctor to better understand the types of vaccines available to you and how to manage getting a vaccine while taking KESIMPTA.

We believe that treatment decisions should be made between you and your health care teams, so please do not stop taking KESIMPTA without first talking to your doctor about any questions you may have.

For more information about COVID-19 vaccines, visit the Centers for Disease Control and Prevention (CDC) website at CDC.gov ↗ and search: COVID-19 vaccines.

Adverse interactions between COVID-19 vaccines and KESIMPTA are not known.

Vaccines like the COVID-19 vaccines are an important part of public health. So, you should talk to your doctor to better understand the types of vaccines available to you and how to manage getting a vaccine while taking KESIMPTA.

We believe that treatment decisions should be made between you and your health care teams, so please do not stop taking KESIMPTA without first talking to your doctor about any questions you may have.

For more information about COVID-19 vaccines, visit the Centers for Disease Control and Prevention (CDC) website at CDC.gov ↗ and search: COVID-19 vaccines.

Studies of vaccine response with KESIMPTA are in progress.

Vaccines like the COVID-19 vaccines are an important part of public health. Novartis is sharing the most up-to-date information regarding its medicines with your doctor. If you have questions, it’s a good idea to check in with them to better understand the types of vaccines available to you and how to manage getting a vaccine while taking KESIMPTA.

For more information about COVID-19 vaccines, visit the Centers for Disease Control and Prevention (CDC) website at CDC.gov ↗ and search: COVID-19 vaccines.

At this time, we do not anticipate any disruption in product supply. We are confident that our existing stock is sufficient to cover production and distribution needs.

If you have concerns about your medication and COVID-19, please reach out to your health care team for further assistance.

While Novartis does not anticipate any supply shortages, the Centers for Disease Control and Prevention (CDC) advises people to get an extra supply of all essential medications. Reach out to your health care team or pharmacy to arrange this.

For more information about CDC recommendations for staying safe during this outbreak, visit cdc.gov/coronavirus/2019-ncov ↗.

We understand these are trying times, and Novartis is committed to making your medication accessible and affordable. If your insurance plan is changing, or you are wondering about your co-pay, you can call Alongside™ KESIMPTA at 1-855-KESIMPTA (1-855-537-4678), 8:30 ᴀᴍ–8:00 ᴘᴍ ET, Mon–Fri. We can help you figure out your options to help make KESIMPTA more affordable.

You could pay as little as $0 for your monthly KESIMPTA prescriptions through the co-pay program* if you have commercial or private prescription insurance. Click here or call 1-855-KESIMPTA (1-855-537-4678), 8:30 ᴀᴍ–8:00 ᴘᴍ ET, Mon–Fri.

Get up to 12 months of KESIMPTA for free.^† If you have commercial or private insurance and your prescription coverage isn’t initially approved, you may get up to 12 months of KESIMPTA for free through Alongside KESIMPTA while we work with your health care provider to try to secure coverage.

Visit the Novartis Patient Assistance Foundation, Inc. (NPAF), if you have limited or no prescription coverage or cannot afford your medication due to employment loss. You may be eligible to receive Novartis medications for free. Learn more at the Novartis Patient Assistance Foundation.

*Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
^†Bridge Program: Must have commercial insurance, a valid prescription for KESIMPTA, and a denial of insurance coverage based on a prior authorization requirement to qualify. Eligible patients may receive a monthly maintenance dose for up to 12 months or until insurance coverage approval, whichever occurs first. Not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, VA, DoD or any other federal or state program, or where prohibited by law. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Other limitations may apply. Novartis reserves the right to rescind, revoke or amend this Program without notice.

We are committed to keeping the relapsing MS community up to date during this uncertain time. If there are any changes, we will reach out via phone/email. You can also follow KESIMPTA on Facebook ↗ to see the latest information.

We believe that treatment decisions should be made with your doctor. Every individual’s medical condition and history are different, and only your health care provider can decide what is right for you in light of COVID-19.

Be sure to call ahead before visiting your doctor. Keep in mind, some health care providers may have adopted phone or video chats (also called telemedicine) as a way to safely meet with patients.

For details regarding the COVID-19 pandemic and recommendations, visit the Centers for Disease Control and Prevention ↗.